Infectious Disease

Significant polarization surrounding COVID-19 vaccinations in late 2020 and early 2021 looked to have had an impact in increasing vaccine hesitancy.

There was a detrimental relationship between COVID-19 caseload and mortality observed across multiple types of hospitals.

Although the investigators commonly detected treatment-emergent resistant variants, they were rare and transient in nature.

Although disease screening reached high-risk patients, uptake was low, necessitating additional incentive to participate in voluntary testing.

The study findings signal the need for improved equality in PrEP prescribing across various institutions and settings.

Long-term shedding of mutated variants could pose a concern for spread among the public.

A 95% increase in private health center participation, monitoring, assessment, and vaccine coverage can be significant in improving outcomes.

Though hospitalizations and test positivity remain at modest levels, wastewater analysis indicates high circulation of SARS-CoV-2, especially in western states.

When IVIG was administered within 48 hours of hospital admission, hospital and ICU length of stay were dramatically shortened.

Despite the new human case, which is not known to be related to animal exposure, the CDC emphasizes that risk to the general public remains low.

By sharpening our vaccine confidence skills and advocating for expanded immunization scopes of practice, we can help improve convenient vaccine access in the US.

Medication therapy management reimbursement can be a driving factor to work toward statin implementation in this patient group.

Let’s shine the spotlight on ourselves, and let’s begin to heal.

Recognizing early signs and seeking medical care is essential for effective treatment and preventing long-term health complications.

The OTC antibody test can detect current or past infection but should be followed by additional testing to confirm diagnosis.

The current outbreak has infected more than 14,000 people and spread to 13 different African countries.

The BLING III trial investigated continuous vs intermittent β-lactam antibiotic infusions in critically ill patients with sepsis, finding no significant difference in 90-day mortality but suggesting potential benefits in clinical cure rates.

Education about prevention measures and early signs and symptoms of the condition are crucial

Pharmacists can also counsel on prevention measures and self-management for fungal infections

Compared to other cases, the most recent patient reported more flu-like symptoms, including cough, congestion, watery eyes, and sore throat.

Outpatient ASPs remain crucial amid rising antimicrobial resistance.

The prevalence of transmission was higher for those who had contact with children aged less than 5 years and aged 5 to 9 years compared with children aged older than 10.

The data were previously presented at the Multilateral Initiative on Malaria 8th Pan-African Malaria Conference and have been submitted for regulatory review.

Speaker Monica Diaz describes the detrimental impact climate change has on the transmission and increases in infectious disease cases.

The 5-in-1 meningococcal ABCWY vaccine candidate has an assigned Prescription Drug User Fee Act action date of February 14, 2025.

New indications include Staphylococcus aureus bloodstream (SAB) infections, acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia.

Scientists hypothesize that fecal microbiota transplant restores the recipient’s gut microbiota to an environment that mimics the healthy donor’s microbiota

The test scans whole blood samples from individual human donors for the 5 parasite species that can cause malaria in humans and detects Plasmodium RNA and DNA.

As data continue to develop in this arena, β-lactam therapeutic drug monitoring is likely to become more routine, as it has with drugs like vancomycin and the aminoglycosides.